UTMD
Utah Medical Products Inc
NASDAQ: UTMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$64.00
-0.50% today
Updated 2026-06-05
Market cap
$221.10M
P/E ratio
20.54
P/S ratio
5.89x
EPS (TTM)
$3.38
Dividend yield
1.79%
52W range
$51 – $72
Volume
0.0M
WallStSmart proprietary scores
50
out of 100
Grade: C
Hold
Investment rating
2.0
Growth
F8.5
Quality
A8.0
Profitability
A3.3
Valuation
D3/9
Piotroski F-Score
Weak
25.0
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$63.76
-0.38%
12-Month target
$63.76
-0.38%
Intrinsic (DCF)
$44.90
Margin of safety
-41.94%
Price chart
Stock snapshot
Strengths
+ Altman Z 24.95 — safe zone
+ Profit margin 28.90% — above average
+ Free cash flow $2.98M — positive
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Revenue declining -10.20% QoQ
- 41.94% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $52.28M | $50.22M | $40.90M | $38.52M | $37.53M |
| Net income | $16.47M | $16.64M | $13.87M | $11.29M | $2.60M |
| EPS | — | — | — | — | $3.38 |
| Free cash flow | $20.33M | $21.64M | $14.60M | $14.32M | $2.98M |
| Profit margin | 31.51% | 33.12% | 33.92% | 29.30% | 28.90% |
Peer comparison
Smart narrative
Utah Medical Products Inc trades at $64.00. representing a P/E of 20.54x trailing earnings. Our Smart Value Score of 50/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 24.95, it sits in the safe zone. TTM revenue stands at $37.53M. with profit margins at 28.90%. Our DCF model estimates intrinsic value at $44.90.
Frequently asked questions
What is Utah Medical Products Inc's stock price?
Utah Medical Products Inc (UTMD) trades at $64.00, on a P/E of 20.5x and a P/S of 5.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Utah Medical Products Inc overvalued?
Utah Medical Products Inc carries a Smart Value Score of 50/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $44.90 against the $64.00 price, so on cash flow terms the market is paying a premium for Utah Medical Products Inc's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Utah Medical Products Inc (UTMD)?
The 12-month analyst consensus target is $63.76, about 0.4% below the current $64.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Utah Medical Products Inc (UTMD)?
Our DCF model estimates intrinsic value at $44.90, a -41.9% margin of safety versus today's $64.00. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Utah Medical Products Inc's revenue?
Utah Medical Products Inc's trailing twelve-month revenue is $37.53M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Utah Medical Products Inc's Altman Z-Score is 24.95, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.89x
ROE9.14%
Beta0.37
50D MA$66.04
200D MA$62.07
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—